Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases

Updated on: August 28,2024

Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases

Updated on:August 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on: January 04,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on:January 04,2024

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on: March 27,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on:March 27,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on: January 02,2024

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on:January 02,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on: March 20,2024

Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressiveness

by Boston University School of MedicineCredit: Pixabay/CC0 Public DomainThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it

Updated on:March 20,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on: March 01,2024

Study: Biomarker in urine may offer noninvasive detection of prostate cancer

by Henry Ford Health SystemNallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, examines prostate cancer cells. Credit: Henry Ford Hea

Updated on:March 01,2024

Researchers trial tiny new microscope to detect breast cancer

by Caroline Brogan,Imperial College LondonMicroscope imaging of invasive breast cancer cells. Credit: Credit: Vyas et al. © Imperial College LondonAn Imperial-developed tiny microscope that can

Updated on: February 23,2024

Researchers trial tiny new microscope to detect breast cancer

by Caroline Brogan,Imperial College LondonMicroscope imaging of invasive breast cancer cells. Credit: Credit: Vyas et al. © Imperial College LondonAn Imperial-developed tiny microscope that can

Updated on:February 23,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on: June 06,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on:June 06,2024

Research shows novel drug pairing could beat pancreatic cancer

byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row

Updated on: January 16,2024

Research shows novel drug pairing could beat pancreatic cancer

byUniversity of California - San DiegoMouse pancreatic tumors were significantly smaller after being treated with a combination of KRAS inhibitor MRTX1133 and ERBB inhibitor Afatinib (bottom row

Updated on:January 16,2024